Covid-19 Impact on Off-body Wearable Injectors Market , Global Research Reports 2020-2021

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Off-body Wearable Injectors Industry

1.7 COVID-19 Impact: Off-body Wearable Injectors Market Trends

2 Global Off-body Wearable Injectors Quarterly Market Size Analysis

2.1 Off-body Wearable Injectors Business Impact Assessment - COVID-19

2.1.1 Global Off-body Wearable Injectors Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Off-body Wearable Injectors Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Off-body Wearable Injectors Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Off-body Wearable Injectors Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Off-body Wearable Injectors Factory Price by Manufacturers

3.3 Location of Key Manufacturers Off-body Wearable Injectors Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Off-body Wearable Injectors Market

3.5 Key Manufacturers Off-body Wearable Injectors Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Off-body Wearable Injectors Segments, By Type

4.1 Introduction

1.4.1 Electronical Injectors

1.4.2 Mechanical Injectors

1.4.3 Others

4.2 By Type, Global Off-body Wearable Injectors Market Size, 2019-2021

4.2.1 By Type, Global Off-body Wearable Injectors Market Size by Type, 2020-2021

4.2.2 By Type, Global Off-body Wearable Injectors Price, 2020-2021

5 Impact of Covid-19 on Off-body Wearable Injectors Segments, By Application

5.1 Overview

5.5.1 Immuno-oncology

5.5.2 Diabetes

5.5.3 Cardiovascular Diseases

5.5.4 Other

5.2 By Application, Global Off-body Wearable Injectors Market Size, 2019-2021

5.2.1 By Application, Global Off-body Wearable Injectors Market Size by Application, 2019-2021

5.2.2 By Application, Global Off-body Wearable Injectors Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 Becton, Dickinson and Company

7.1.1 Becton, Dickinson and Company Business Overview

7.1.2 Becton, Dickinson and Company Off-body Wearable Injectors Quarterly Production and Revenue, 2020

7.1.3 Becton, Dickinson and Company Off-body Wearable Injectors Product Introduction

7.1.4 Becton, Dickinson and Company Response to COVID-19 and Related Developments

7.2 Medtronic

7.2.1 Medtronic Business Overview

7.2.2 Medtronic Off-body Wearable Injectors Quarterly Production and Revenue, 2020

7.2.3 Medtronic Off-body Wearable Injectors Product Introduction

7.2.4 Medtronic Response to COVID-19 and Related Developments

7.3 Johnson & Johnson

7.3.1 Johnson & Johnson Business Overview

7.3.2 Johnson & Johnson Off-body Wearable Injectors Quarterly Production and Revenue, 2020

7.3.3 Johnson & Johnson Off-body Wearable Injectors Product Introduction

7.3.4 Johnson & Johnson Response to COVID-19 and Related Developments

7.4 Insulet Corporation

7.4.1 Insulet Corporation Business Overview

7.4.2 Insulet Corporation Off-body Wearable Injectors Quarterly Production and Revenue, 2020

7.4.3 Insulet Corporation Off-body Wearable Injectors Product Introduction

7.4.4 Insulet Corporation Response to COVID-19 and Related Developments

7.5 Unilife Corporation

7.5.1 Unilife Corporation Business Overview

7.5.2 Unilife Corporation Off-body Wearable Injectors Quarterly Production and Revenue, 2020

7.5.3 Unilife Corporation Off-body Wearable Injectors Product Introduction

7.5.4 Unilife Corporation Response to COVID-19 and Related Developments

7.6 Enable Injections

7.6.1 Enable Injections Business Overview

7.6.2 Enable Injections Off-body Wearable Injectors Quarterly Production and Revenue, 2020

7.6.3 Enable Injections Off-body Wearable Injectors Product Introduction

7.6.4 Enable Injections Response to COVID-19 and Related Developments

7.7 SteadyMed

7.7.1 SteadyMed Business Overview

7.7.2 SteadyMed Off-body Wearable Injectors Quarterly Production and Revenue, 2020

7.7.3 SteadyMed Off-body Wearable Injectors Product Introduction

7.7.4 SteadyMed Response to COVID-19 and Related Developments

7.8 Ypsomed Group

7.8.1 Ypsomed Group Business Overview

7.8.2 Ypsomed Group Off-body Wearable Injectors Quarterly Production and Revenue, 2020

7.8.3 Ypsomed Group Off-body Wearable Injectors Product Introduction

7.8.4 Ypsomed Group Response to COVID-19 and Related Developments

7.9 West Pharmaceutical Services

7.9.1 West Pharmaceutical Services Business Overview

7.9.2 West Pharmaceutical Services Off-body Wearable Injectors Quarterly Production and Revenue, 2020

7.9.3 West Pharmaceutical Services Off-body Wearable Injectors Product Introduction

7.9.4 West Pharmaceutical Services Response to COVID-19 and Related Developments

7.10 Unilife

7.10.1 Unilife Business Overview

7.10.2 Unilife Off-body Wearable Injectors Quarterly Production and Revenue, 2020

7.10.3 Unilife Off-body Wearable Injectors Product Introduction

7.10.4 Unilife Response to COVID-19 and Related Developments

7.11 CeQur

7.11.1 CeQur Business Overview

7.11.2 CeQur Off-body Wearable Injectors Quarterly Production and Revenue, 2020

7.11.3 CeQur Off-body Wearable Injectors Product Introduction

7.11.4 CeQur Response to COVID-19 and Related Developments

7.12 Sensile Medical

7.12.1 Sensile Medical Business Overview

7.12.2 Sensile Medical Off-body Wearable Injectors Quarterly Production and Revenue, 2020

7.12.3 Sensile Medical Off-body Wearable Injectors Product Introduction

7.12.4 Sensile Medical Response to COVID-19 and Related Developments

7.13 Roche

7.13.1 Roche Business Overview

7.13.2 Roche Off-body Wearable Injectors Quarterly Production and Revenue, 2020

7.13.3 Roche Off-body Wearable Injectors Product Introduction

7.13.4 Roche Response to COVID-19 and Related Developments

7.14 ScPharmaceuticals

7.14.1 ScPharmaceuticals Business Overview

7.14.2 ScPharmaceuticals Off-body Wearable Injectors Quarterly Production and Revenue, 2020

7.14.3 ScPharmaceuticals Off-body Wearable Injectors Product Introduction

7.14.4 ScPharmaceuticals Response to COVID-19 and Related Developments

7.15 SteadyMed

7.15.1 SteadyMed Business Overview

7.15.2 SteadyMed Off-body Wearable Injectors Quarterly Production and Revenue, 2020

7.15.3 SteadyMed Off-body Wearable Injectors Product Introduction

7.15.4 SteadyMed Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Off-body Wearable Injectors Supply Chain Analysis

8.1.1 Off-body Wearable Injectors Supply Chain Analysis

8.1.2 Covid-19 Impact on Off-body Wearable Injectors Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Off-body Wearable Injectors Distribution Channels

8.2.2 Covid-19 Impact on Off-body Wearable Injectors Distribution Channels

8.2.3 Off-body Wearable Injectors Distributors

8.3 Off-body Wearable Injectors Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Off-body Wearable Injectors Assessment

Table 9. COVID-19 Impact: Off-body Wearable Injectors Market Trends

Table 10. COVID-19 Impact Global Off-body Wearable Injectors Market Size

Table 11. Global Off-body Wearable Injectors Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

Table 12. Global Off-body Wearable Injectors Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (US$/Unit)

Table 13. Global Off-body Wearable Injectors Quarterly Market Size, 2020 (US$ Million) & (K Units)

Table 14. Global Off-body Wearable Injectors Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Off-body Wearable Injectors Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

Table 16. Global Off-body Wearable Injectors Market Growth Drivers

Table 17. Global Off-body Wearable Injectors Market Restraints

Table 18. Global Off-body Wearable Injectors Market Opportunities

Table 19. Global Off-body Wearable Injectors Market Challenges

Table 20. Key Manufacturers Off-body Wearable Injectors Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Off-body Wearable Injectors Market Size, 2019 (K Units) & (US$ Million)

Table 22. Off-body Wearable Injectors Factory Price by Manufacturers 2020 (US$/Unit)

Table 23. Location of Key Manufacturers Off-body Wearable Injectors Manufacturing Plants

Table 24. Key Manufacturers Off-body Wearable Injectors Market Served

Table 25. Date of Key Manufacturers Enter into Off-body Wearable Injectors Market

Table 26. Key Manufacturers Off-body Wearable Injectors Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Off-body Wearable Injectors Market Size by Type, 2020, (US$ Million)

Table 29. Global Off-body Wearable Injectors Market Size by Type, 2020 (K Units)

Table 30. Global Off-body Wearable Injectors Price: by Type, 2020-2021 (US$/Unit)

Table 31. Global Off-body Wearable Injectors Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Off-body Wearable Injectors Market Size by Application, 2020-2021 (K Units)

Table 33. Global Off-body Wearable Injectors Price: by Application, 2020-2021 (US$/Unit)

Table 34. Global Off-body Wearable Injectors Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Off-body Wearable Injectors Market Size by Region, 2019-2021 (K Units)

Table 36. By Country, North America Off-body Wearable Injectors Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Off-body Wearable Injectors Market Size, 2019-2021 (K Units)

Table 38. US Off-body Wearable Injectors Market Size, 2019-2021 (US$ Million) & (K Units)

Table 39. Canada Off-body Wearable Injectors Market Size, 2019-2021 (US$ Million) & (K Units)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Off-body Wearable Injectors Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Off-body Wearable Injectors Market Size, 2019-2021 (K Units)

Table 43. Germany Off-body Wearable Injectors Market Size, 2019-2021 (US$ Million) & (K Units)

Table 44. France Off-body Wearable Injectors Market Size, 2019-2021 (US$ Million) & (K Units)

Table 45. UK Off-body Wearable Injectors Market Size, 2019-2021 (US$ Million) & (K Units)

Table 46. Italy Off-body Wearable Injectors Market Size, 2019-2021 (US$ Million) & (K Units)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Off-body Wearable Injectors Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Off-body Wearable Injectors Market Size, 2019-2021 (K Units)

Table 50. China Off-body Wearable Injectors Market Size, 2019-2021 (US$ Million) & (K Units)

Table 51. Japan Off-body Wearable Injectors Market Size, 2019-2021 (US$ Million) & (K Units)

Table 52. South Korea Off-body Wearable Injectors Market Size, 2019-2021 (US$ Million) & (K Units)

Table 53. India Off-body Wearable Injectors Market Size, 2019-2021 (US$ Million) & (K Units)

Table 54. ASEAN Off-body Wearable Injectors Market Size, 2019-2021 (US$ Million) & (K Units)

Table 55. Latin America Off-body Wearable Injectors Market Size, 2019-2021 (US$ Million) & (K Units)

Table 56. Middle East and Africa Off-body Wearable Injectors Market Size, 2019-2021 (US$ Million) & (K Units)

Table 57. Becton, Dickinson and Company Business Overview

Table 58. Becton, Dickinson and Company Off-body Wearable Injectors Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Becton, Dickinson and Company Off-body Wearable Injectors Product

Table 60. Becton, Dickinson and Company Response to COVID-19 and Related Developments

Table 61. Medtronic Business Overview

Table 62. Medtronic Off-body Wearable Injectors Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Medtronic Off-body Wearable Injectors Product

Table 64. Medtronic Response to COVID-19 and Related Developments

Table 65. Johnson & Johnson Business Overview

Table 66. Johnson & Johnson Off-body Wearable Injectors Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Johnson & Johnson Off-body Wearable Injectors Product

Table 68. Johnson & Johnson Response to COVID-19 and Related Developments

Table 69. Insulet Corporation Business Overview

Table 70. Insulet Corporation Off-body Wearable Injectors Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Insulet Corporation Off-body Wearable Injectors Product

Table 72. Insulet Corporation Response to COVID-19 and Related Developments

Table 73. Unilife Corporation Business Overview

Table 74. Unilife Corporation Off-body Wearable Injectors Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Unilife Corporation Off-body Wearable Injectors Product

Table 76. Unilife Corporation Response to COVID-19 and Related Developments

Table 77. Enable Injections Business Overview

Table 78. Enable Injections Off-body Wearable Injectors Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Enable Injections Off-body Wearable Injectors Product

Table 80. Enable Injections Response to COVID-19 and Related Developments

Table 81. SteadyMed Business Overview

Table 82. SteadyMed Off-body Wearable Injectors Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. SteadyMed Off-body Wearable Injectors Product

Table 84. SteadyMed Response to COVID-19 and Related Developments

Table 85. Ypsomed Group Business Overview

Table 86. Ypsomed Group Off-body Wearable Injectors Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Ypsomed Group Off-body Wearable Injectors Product

Table 88. Ypsomed Group Response to COVID-19 and Related Developments

Table 89. West Pharmaceutical Services Business Overview

Table 90. West Pharmaceutical Services Off-body Wearable Injectors Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. West Pharmaceutical Services Off-body Wearable Injectors Product

Table 92. West Pharmaceutical Services Response to COVID-19 and Related Developments

Table 93. Unilife Business Overview

Table 94. Unilife Off-body Wearable Injectors Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Unilife Off-body Wearable Injectors Product

Table 96. Unilife Response to COVID-19 and Related Developments

Table 97. CeQur Business Overview

Table 98. CeQur Off-body Wearable Injectors Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. CeQur Off-body Wearable Injectors Product

Table 100. CeQur Response to COVID-19 and Related Developments

Table 101. Sensile Medical Business Overview

Table 102. Sensile Medical Off-body Wearable Injectors Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. Sensile Medical Off-body Wearable Injectors Product

Table 104. Sensile Medical Response to COVID-19 and Related Developments

Table 105. Roche Business Overview

Table 106. Roche Off-body Wearable Injectors Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 107. Roche Off-body Wearable Injectors Product

Table 108. Roche Response to COVID-19 and Related Developments

Table 109. ScPharmaceuticals Business Overview

Table 110. ScPharmaceuticals Off-body Wearable Injectors Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 111. ScPharmaceuticals Off-body Wearable Injectors Product

Table 112. ScPharmaceuticals Response to COVID-19 and Related Developments

Table 113. SteadyMed Business Overview

Table 114. SteadyMed Off-body Wearable Injectors Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 115. SteadyMed Off-body Wearable Injectors Product

Table 116. SteadyMed Response to COVID-19 and Related Developments

Table 117. Off-body Wearable Injectors Distributors List

Table 118. Off-body Wearable Injectors Customers List

Table 119. Covid-19 Impact on Off-body Wearable Injectors Customers

List of Figures

Figure 1. Off-body Wearable Injectors Product Picture

Figure 2. Off-body Wearable Injectors Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Off-body Wearable Injectors Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Off-body Wearable Injectors Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Off-body Wearable Injectors Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Off-body Wearable Injectors Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Off-body Wearable Injectors Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Off-body Wearable Injectors Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Off-body Wearable Injectors Market Size Market Share, 2019-2021